Related Experiment Video
Updated: Jul 9, 2026

Direct Detection of the Acetate-forming Activity of the Enzyme Acetate Kinase
Published on: December 19, 2011
Skin acetone as a clinical diagnostic biomarker of ketosis
Anh Ngan Nguyen1,2,3, Oscar Osorio-Perez1,2,3,4, David Jackemeyer2,3
1School of Engineering for Matter, Transport and Energy, Arizona State University, Tempe, AZ, USA.
Background/Objective:
We present the first receiver operating characteristic (ROC) diagnostic analysis of skin-excreted acetone as a biomarker of ketosis.
Participants/Methods:
In an 8-week controlled crossover pilot study (n = 16), we evaluated the ability of skin-emitted acetone to differentiate metabolic ketosis from non-ketosis states. Non-ketosis was established via a normal diet/energy balance, while ketosis was induced through dietary and energy manipulations, including ketogenic diets and negative energy balances. Alongside skin acetone concentration and excretion rate, we quantified a comprehensive set of ketone body parameters for comparative diagnostic purposes, including breath acetone concentration and excretion rate, blood beta-hydroxybutyrate concentration, urine beta-hydroxybutyrate concentration and excretion rate, and urine acetoacetate concentration and excretion rate. Blood BHB (mM) served as the clinical benchmark for ketosis.
Results:
ROC curves were generated to evaluate the diagnostic performance of each biomarker in distinguishing between ketosis and non-ketosis. Both breath and skin acetone excretion rates achieved an area under the curve (AUC) of 0.83, outperforming several other ketone biomarkers. Similarly, breath acetone and skin acetone concentrations also exhibited AUCs of 0.82 and 0.83, respectively. In comparison, blood beta-hydroxybutyrate concentration and urine acetoacetate excretion rate both showed an AUC of 0.81, while urine beta-hydroxybutyrate excretion rate and concentration achieved AUCs of 0.66 and 0.68, respectively. Furthermore, breath and skin acetone excretion rates were systematically compared within and across participants. The correlation between the two reinforces the significance of skin acetone as a body ketone biomarker that diffuses through the skin, representing the body's acetone concentrations.
Conclusions:
Overall, the results highlight the potential of skin acetone excretion rate as a reliable, non-invasive biomarker of ketosis, with diagnostic accuracy comparable to that of blood-based standards, offering significant promise for continuous, wearable metabolic monitoring in clinical and health settings.
Related Concept Videos
Diabetic Ketoacidosis l: Introduction
Diabetic Ketoacidosis ll: Pathophysiology
NMR Spectroscopy and Mass Spectrometry of Aldehydes and Ketones
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Alkylation of β-Ketoester Enolates: Acetoacetic Ester Synthesis
IUPAC Nomenclature of Ketones
